Quanterix Corporation Cash and Restricted Cash
Quanterix Corporation (QTRX) had Cash and Restricted Cash of $47.52 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $47.52M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.53M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.18M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41.63M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $47.52M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $39.53M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $33.18M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $41.63M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $135.54M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $79.15M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $59.32M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $31.95M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $49.61M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $47.89M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $177.03M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $203.86M 10-K/A · filed 2024-12-26 | $203.91M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $332.13M 10-K/A · filed 2024-12-26 | $332.21M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $331.95M 10-K/A · filed 2024-12-26 | $332.27M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $341.34M 10-K · filed 2026-03-02 | |
| 2022-09-30 | $346.34M 10-K/A · filed 2024-12-26 | |
| 2022-06-30 | $364.14M 10-K/A · filed 2024-12-26 | $363.89M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $377.12M 10-K/A · filed 2024-12-26 | $376.89M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $399.27M 10-K · filed 2025-03-17 | $399.04M 10-K · filed 2022-03-01 |
| 2021-09-30 | $412.40M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $432.18M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $444.07M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $182.58M 10-K/A · filed 2024-12-26 | |
| 2020-09-30 | $174.16M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $89.81M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $97.36M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $110.18M 10-K · filed 2023-03-06 | |
| 2019-09-30 | $114.35M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $73.05M 10-Q · filed 2020-08-04 | |
| 2019-03-31 | $34.99M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $45.43M 10-K · filed 2022-03-01 | |
| 2018-09-30 | $52.42M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $60.47M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $65.23M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $79.68M 10-K · filed 2021-03-05 | |
| 2017-09-30 | $18.69M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $26.29M 10-Q · filed 2018-08-10 | |
| 2016-12-31 | $29.67M 10-K · filed 2020-03-13 | |
| 2015-12-31 | $2.32M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |